Ashok Leyland Q1 FY27 Results Analysis: Margin Compresses 105 bps, Impairment Losses Jump 47.8% (ASHOKLEY)

Cofacto Research Updated August 14, 2026 2 min read
Neutral

Ashok Leyland Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 9,634.35 Cr (+10.43% YoY) and PAT growth of +2.59% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateAugust 14, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 9,634.35 Cr (+10.43% YoY)
PAT (Q1)Rs. 609.11 Cr (+2.59% YoY)
EBITDA margin10.06% (-105 bps YoY)
EPS (Q1)Rs. 1.04 (+2.97% YoY)
Market capRs. 100,532.31 Cr
CMPRs. 171.90

Quarter Snapshot

Ashok Leyland reported record Q1 revenue and volumes in the CV segment, with MHCV and LCV both posting double-digit growth. However, standalone EBITDA margin compressed 105 bps YoY due to cost pressures, and the financial services segment saw a sharp 47.8% jump in impairment losses. Export volumes declined 18% YoY and the HLF merger listing was delayed, tempering the positive volume news.

Key Investment Insights

Key Positives

  • Standalone revenue of Rs.9,634 Cr, highest ever Q1, growing 10.43% YoY
  • Total CV volumes at 48,763 units, a Q1 record, with MHCV ex-Defence up 15% and LCV domestic up 21% YoY
  • Standalone net cash position improved to Rs.2,252 Cr, near debt-free balance sheet (D/E 0.08x)
  • No exceptional items in the quarter; normalized PAT equals reported PAT
  • CV segment revenue grew 9.6% YoY driven by volume growth

Risk Factors

  • Standalone EBITDA margin compressed 105 bps YoY to 10.06%, driven by cost pressure and flat EBITDA
  • Consolidated impairment loss in financial services rose 47.8% YoY to Rs.471.96 Cr, compressing FS segment margin by 204 bps
  • Export volumes declined 18.3% YoY to 2,461 units, missing the 20% CAGR trajectory
  • HLF merger listing target for Q1 FY27 was missed; NCLT application filed only on June 1, 2026
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now